{"id":15793,"date":"2024-01-19T09:25:43","date_gmt":"2024-01-19T08:25:43","guid":{"rendered":"https:\/\/norens.se\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/"},"modified":"2024-01-19T09:28:29","modified_gmt":"2024-01-19T08:28:29","slug":"norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech","status":"publish","type":"post","link":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/","title":{"rendered":"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech"},"content":{"rendered":"\n<p>Nor\u00e9ns advises private equity giant EQT on patent matters in connection with the acquisition of the biotech company Mabtech. <\/p>\n\n<p>Mabtech is a leading provider of antibodies, kits and platforms for life science research. The company is based in Sweden and has over 900 customers in more than 60 countries. The company had a turnover of 247 million SEK and made a profit of 76 million SEK in 2022.<\/p>\n\n<p>As of 2022, EQT&#8217;s assets under management are \u20ac210 billion \/ US$227 billion and it is ranked the third largest private equity firm worldwide based on funds raised.  The transaction is subject to conditions and approvals and is expected to close in Q1 2024. <\/p>\n\n<p>The Nor\u00e9ns team consisted of Anders Bratt and Johan St\u00e5hlberg. <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nor\u00e9ns advises private equity giant EQT on patent matters in connection with the acquisition of the biotech company Mabtech. Mabtech is a leading provider of antibodies, kits and platforms for life science research. The company is based in Sweden and has over 900 customers in more than 60 countries. The company had a turnover of [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[83,85],"tags":[],"class_list":["post-15793","post","type-post","status-publish","format-standard","hentry","category-news","category-patent-en-2"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech - Nor\u00e9ns Patentbyr\u00e5<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech - Nor\u00e9ns Patentbyr\u00e5\" \/>\n<meta property=\"og:description\" content=\"Nor\u00e9ns advises private equity giant EQT on patent matters in connection with the acquisition of the biotech company Mabtech. Mabtech is a leading provider of antibodies, kits and platforms for life science research. The company is based in Sweden and has over 900 customers in more than 60 countries. The company had a turnover of [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/\" \/>\n<meta property=\"og:site_name\" content=\"Nor\u00e9ns Patentbyr\u00e5\" \/>\n<meta property=\"article:published_time\" content=\"2024-01-19T08:25:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-19T08:28:29+00:00\" \/>\n<meta name=\"author\" content=\"Clara Cardell\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Clara Cardell\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/\"},\"author\":{\"name\":\"Clara Cardell\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#\\\/schema\\\/person\\\/b3e0a65a512885a187f87c3cab2e1a28\"},\"headline\":\"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech\",\"datePublished\":\"2024-01-19T08:25:43+00:00\",\"dateModified\":\"2024-01-19T08:28:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/\"},\"wordCount\":128,\"publisher\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#organization\"},\"articleSection\":[\"NEWS\",\"Patent\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/\",\"url\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/\",\"name\":\"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech - Nor\u00e9ns Patentbyr\u00e5\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#website\"},\"datePublished\":\"2024-01-19T08:25:43+00:00\",\"dateModified\":\"2024-01-19T08:28:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/norens.se\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/norens.se\\\/en\\\/\",\"name\":\"Nor\u00e9ns Patentbyr\u00e5\",\"description\":\"PATENT TRADEMARK DESIGN\",\"publisher\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/norens.se\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#organization\",\"name\":\"Norens Patentbyr\u00e5\",\"url\":\"https:\\\/\\\/norens.se\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/norens.se\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/NORENS_1000.png\",\"contentUrl\":\"https:\\\/\\\/norens.se\\\/wp-content\\\/uploads\\\/2019\\\/09\\\/NORENS_1000.png\",\"width\":1000,\"height\":152,\"caption\":\"Norens Patentbyr\u00e5\"},\"image\":{\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/norens.se\\\/en\\\/#\\\/schema\\\/person\\\/b3e0a65a512885a187f87c3cab2e1a28\",\"name\":\"Clara Cardell\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50164a7db3588caf3fa42ec1125333bb737cbb1d513ed07ca7a361e26e43d2df?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50164a7db3588caf3fa42ec1125333bb737cbb1d513ed07ca7a361e26e43d2df?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/50164a7db3588caf3fa42ec1125333bb737cbb1d513ed07ca7a361e26e43d2df?s=96&d=mm&r=g\",\"caption\":\"Clara Cardell\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech - Nor\u00e9ns Patentbyr\u00e5","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/","og_locale":"en_US","og_type":"article","og_title":"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech - Nor\u00e9ns Patentbyr\u00e5","og_description":"Nor\u00e9ns advises private equity giant EQT on patent matters in connection with the acquisition of the biotech company Mabtech. Mabtech is a leading provider of antibodies, kits and platforms for life science research. The company is based in Sweden and has over 900 customers in more than 60 countries. The company had a turnover of [&hellip;]","og_url":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/","og_site_name":"Nor\u00e9ns Patentbyr\u00e5","article_published_time":"2024-01-19T08:25:43+00:00","article_modified_time":"2024-01-19T08:28:29+00:00","author":"Clara Cardell","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Clara Cardell","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/#article","isPartOf":{"@id":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/"},"author":{"name":"Clara Cardell","@id":"https:\/\/norens.se\/en\/#\/schema\/person\/b3e0a65a512885a187f87c3cab2e1a28"},"headline":"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech","datePublished":"2024-01-19T08:25:43+00:00","dateModified":"2024-01-19T08:28:29+00:00","mainEntityOfPage":{"@id":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/"},"wordCount":128,"publisher":{"@id":"https:\/\/norens.se\/en\/#organization"},"articleSection":["NEWS","Patent"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/","url":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/","name":"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech - Nor\u00e9ns Patentbyr\u00e5","isPartOf":{"@id":"https:\/\/norens.se\/en\/#website"},"datePublished":"2024-01-19T08:25:43+00:00","dateModified":"2024-01-19T08:28:29+00:00","breadcrumb":{"@id":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/norens.se\/en\/norens-advises-eqt-in-connection-with-its-acquisition-of-mabtech\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/norens.se\/en\/"},{"@type":"ListItem","position":2,"name":"Nor\u00e9ns advises EQT in connection with its acquisition of Mabtech"}]},{"@type":"WebSite","@id":"https:\/\/norens.se\/en\/#website","url":"https:\/\/norens.se\/en\/","name":"Nor\u00e9ns Patentbyr\u00e5","description":"PATENT TRADEMARK DESIGN","publisher":{"@id":"https:\/\/norens.se\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/norens.se\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/norens.se\/en\/#organization","name":"Norens Patentbyr\u00e5","url":"https:\/\/norens.se\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/norens.se\/en\/#\/schema\/logo\/image\/","url":"https:\/\/norens.se\/wp-content\/uploads\/2019\/09\/NORENS_1000.png","contentUrl":"https:\/\/norens.se\/wp-content\/uploads\/2019\/09\/NORENS_1000.png","width":1000,"height":152,"caption":"Norens Patentbyr\u00e5"},"image":{"@id":"https:\/\/norens.se\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/norens.se\/en\/#\/schema\/person\/b3e0a65a512885a187f87c3cab2e1a28","name":"Clara Cardell","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/50164a7db3588caf3fa42ec1125333bb737cbb1d513ed07ca7a361e26e43d2df?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/50164a7db3588caf3fa42ec1125333bb737cbb1d513ed07ca7a361e26e43d2df?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/50164a7db3588caf3fa42ec1125333bb737cbb1d513ed07ca7a361e26e43d2df?s=96&d=mm&r=g","caption":"Clara Cardell"}}]}},"_links":{"self":[{"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/posts\/15793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/comments?post=15793"}],"version-history":[{"count":1,"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/posts\/15793\/revisions"}],"predecessor-version":[{"id":15794,"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/posts\/15793\/revisions\/15794"}],"wp:attachment":[{"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/media?parent=15793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/categories?post=15793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/norens.se\/en\/wp-json\/wp\/v2\/tags?post=15793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}